Containment Guidance and Tools
GAPIII and Containment Certification Scheme
The WHO Global Action Plan (GAPIII) is the chief guidance document for poliovirus containment. It was endorsed by the WHO Strategic Advisory Group of Experts on Immunization (SAGE) in October 2014 and through World Health Assembly resolution WHA68.3 in May 2015. The GAPIII Containment Certification Scheme (CCS), to support implementation of GAPIII, was endorsed by SAGE in October 2016.
In 2018, SAGE transferred the function of oversight of containment and containment-related documents to WHO’s Containment Advisory Group (CAG).
On recommendation from the CAG and through wide engagement of stakeholders, GAPIII has been revised. Revisions to the guidance have been made based on CAG recommendations, review of relevant biorisk management documents to determine alignment, scientific evidence and solicited stakeholder comments on various sections.
The document has recently made available for public consultation (April 2022). CAG will now conduct a critical review of stakeholder feedback in order to endorse any final changes ahead of publication. Updates on publication will be posted on this page.For queries, please email: email@example.com
The following Containment Certification Scheme forms and templates are available to support National Authorities for Containment in the roll-out and implementation of the certification process. All submissions to the Global Certification Commission for the Eradication of Poliomyelitis (GCC) must be made in English.
Guidance to minimize risks for facilities collecting, handling or storing materials potentially infectious for polioviruses (PIM Guidance) – 2nd edition
This guidance aims to facilitate the identification of materials potentially infectious for polioviruses within laboratories that handle human stool specimens, respiratory samples or environmental sewage. Depending on the place and time of collection, these materials may contain infectious polioviruses that are eradicated (WPV2 and WPV3), nearly eradicated (WPV1) or originating from oral polio vaccines. Identifying, eliminating the risk through destruction, or mitigating the risk of handling such materials is essential, not only to maintain the safety of laboratory workers and their communities, but also for the success of the global polio eradication effort.
Facilities are encouraged to use Web Annex A to assess the risk of sample collections potentially infectious for poliovirus, and Web Annex B to complete the form available as Web Annex C. Web Annex D helps national focal points complete the progress reporting form describing preparations for poliovirus containment.
Here is the newly launched Potentially Infectious Materials, Poliovirus (PIM) Identification Tool.
- PIM Guidance 2nd edition
- Web Annex A: Country- and area-specific poliovirus data
- Web Annex B: SOP for the identification, destruction or preparation for containment of poliovirus infectious or potentially infectious materials
- Web Annex C: Form 1 – Facility reporting form
- Web Annex D: Form 2 – Progress reporting form on preparations for poliovirus containment and completion of Phase I of GAPIII
Public Health Management of Facility Related Exposure to Live Polioviruses
WHO has published guidance for managing human exposure to live polioviruses in laboratory facilities. Countries where polioviruses are kept require this guidance.
The document is primarily aimed at workers handling and storing polioviruses in designated poliovirus-essential facilities and outlines public health measures to be taken in the event of a spill or containment breach.
- Public Health Management of Facility Related Exposure to Live Polioviruses | English | French | Arabic | Spanish |